Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-055951

LA JOLLA PHARMACEUTICAL CO · LJPC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Kevin C Tang
Director · 10% Owner
Period of report
Jun 22, 2015
Accepted (ET)
Jun 24, 2015 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jun 22, 2015P77,850$21.4078A2,369,980IBy LP
Common StockF1Jun 23, 2015P53,836$22.2665A2,423,816IBy LP
Common StockF1Jun 24, 2015P88,314$22.943A2,512,130IBy LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses